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It is not clear whether alcohol consumption is associated with lung cancer risk. The relationship is likely confounded by smok-
ing, complicating the interpretation of previous studies. We examined the association of alcohol consumption and lung cancer
risk in a large pooled international sample, minimizing potential confounding of tobacco consumption by restricting analyses to
never smokers. Our study included 22 case-control and cohort studies with a total of 2548 never-smoking lung cancer patients
and 9362 never-smoking controls from North America, Europe and Asia within the International Lung Cancer Consortium (ILCCO)
and SYNERGY Consortium. Alcohol consumption was categorized into amounts consumed (grams per day) and also modelled as
a continuous variable using restricted cubic splines for potential non-linearity. Analyses by histologic sub-type were included.
Associations by type of alcohol consumed (wine, beer and liquor) were also investigated. Alcohol consumption was inversely
associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to
non-drinkers (>0–4.9 g per day: OR50.80, 95% CI50.70–0.90; 5–9.9 g per day: OR50.82, 95% CI50.69–0.99; 10–19.9 g
per day: OR50.79, 95% CI50.65–0.96). Inverse associations were found for consumption of wine and liquor, but not beer. The
results indicate that alcohol consumption is inversely associated with lung cancer risk, particularly among subjects with low to
moderate consumption levels, and among wine and liquor drinkers, but not beer drinkers. Although our results should have no
relevant bias from the confounding effect of smoking we cannot preclude that confounding by other factors contributed to the
observed associations. Confounding in relation to the non-drinker reference category may be of particular importance.
Lung cancer continues to be the most common cancer and the
leading cause of cancer death worldwide, with 1.8 million new
cases and 1.6 million deaths reported annually.1 Tobacco
smoking is the primary cause of lung cancer accounting for
>80% of all lung cancer diagnoses.2 Other known risk factors
include exposure to occupational and environmental
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carcinogens such as asbestos and radon.3,4 Although less com-
mon than lung cancer in smokers, lung cancer among never
smokers still impacts a signiﬁcant portion of the population, and
is recognized as the seventh most common cause of cancer mor-
tality worldwide.5
Alcohol is classiﬁed as a Group 1 carcinogen by the Interna-
tional Agency for Research on Cancer, and it has been hypoth-
esized that alcohol consumption may modulate lung cancer
risk. However, deﬁnite conclusions could not be drawn from
previous epidemiologic investigations because of inconsistent
results across studies.6–9 Since alcohol intake is strongly corre-
lated with tobacco smoking,9 the confounding effect poses the
main methodological challenge when investigating alcohol
consumption and lung cancer risk. Although few previous
studies have investigated the association between alcohol con-
sumption and lung cancer risk in never smokers, they were
limited in precision. Furthermore, associations by histologic
subtype and beverage type (e.g., wine, beer and liquor) have
not been thoroughly investigated among never smokers.8,10,11
In this study, we investigated the association of alcohol
consumption and lung cancer risk in never smokers in a
large pooled dataset of 22 studies from the International
Lung Cancer Consortium (ILCCO)12 and the SYNERGY pro-
ject,13 in order to obtain sufﬁcient sample size to thoroughly
examine this association stratiﬁed by histologic subtype and
beverage type while minimizing the effect of residual con-
founding by smoking.
Material and Methods
Study populations
Details regarding ILCCO and SYNERGY have been reported
previously12,13 and are available on web portals http://ilcco.
iarc.fr and http://synergy.iarc.fr. Twenty-two studies from
these consortia provided data for this analysis, including 10
studies in North America, seven studies in Europe and ﬁve
studies in Asia or other areas. All studies were either case-
control or analyzed as nested case-control data sets, with 11
population-based, seven hospital-based, three with mixed
control groups and one cohort (Supporting Information
Table 1 for further details). Control groups were at minimum
matched on age and sex. Each study received approval from
local ethics review boards.
Assessments of alcohol consumption
Consumption of alcohol and tobacco smoking was collected in
each study by questionnaire. Never-smokers were deﬁned as
those who smoked <100 cigarettes in their lifetime whenever
this information is available, or based on study questionnaire.
Non-drinkers were deﬁned as those who did not consume alco-
hol, or at least occasionally, in their lifetime (Supporting Infor-
mation Table 2). Most studies (n5 18) included details
regarding quantity and type of alcohol consumed (e.g., beer,
wine and liquor) and duration of drinking. Some question-
naires included additional types of alcohol (e.g., Aperatif, Soku,
Sachi), which were included in the estimation of average life-
time alcohol consumption (Supporting Information Table 2).
Duration of drinking data were generally available for multiple
time periods (Supporting Information Table 2).
Amount of alcohol consumption was converted to stan-
dardized drink units. These were then converted to grams
per day using 12 g of alcohol per drink unit based on on-line
data from the International Agency for Research on Cancer
(http://cancer-code-europe.iarc.fr/) and the Canadian Nutri-
ent File by Health Canada. Lifetime average grams of alcohol
consumed per day (overall and separately by beverage types)
were estimated based on consumption frequency, changes in
consumption patterns over the lifetime and beverage-speciﬁc
alcohol content. For four studies where duration data were
not available, we used current drinking as a proxy for average
lifetime alcohol consumption. Non-drinkers were chosen as
the reference category (instead of combining non-drinkers
with low-level drinkers) to ensure that lung cancer risk relat-
ed to low amounts of alcohol consumption could be assessed
and that our results were comparable to previous large stud-
ies which also chose non-drinkers as the reference group. We
also created detailed categories to capture the dose-response
relationship for moderate and heavy alcohol consumption.
Statistical analysis
We applied unconditional logistic regression to estimate odds
ratios and conﬁdence limits for the association of average
lifetime alcohol consumption with lung cancer risk based on
the pooled dataset. To understand the association for differ-
ent lung cancer histological subtypes we examined associa-
tions separately by histology. We also modelled average
lifetime grams per day of wine consumption, beer consump-
tion and liquor consumption separately for lung cancer risk,
mutually adjusted by beverage type. The potential non-linear
dose-response relationship was assessed using restricted cubic
splines. All models were adjusted for sex, age, ethnicity, edu-
cation and study centre/sub-centre. Race/ethnicity was
What’s new?
When considering how alcohol affects lung cancer risk, it’s been challenging to tease out the impact of alcohol from that of
smoking. Now, these authors have pooled data from 22 international studies involving only people who have never smoked.
They’ve conducted the largest case-control analysis to date looking at alcohol and lung cancer risk in the absence of tobacco.
People who drank low to moderate amounts of wine and liquor particularly – not beer – did have a lower risk of lung cancer,
although confounding by factors other than smoking, particularly in relation to the non-drinkers reference group, cannot be
ruled out.
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collected according to investigator chosen categories (Table
1). We chose to adjust for race/ethnicity because alcohol con-
sumption and lung cancer risk in non-smokers has been
found to vary across race/ethnicity groups14,15 indicating that
race/ethnicity could confound the association between alcohol
intake and lung cancer risk.
Because metabolism of alcohol varies between sexes, we
conducted sex-speciﬁc analyses for overall alcohol consump-
tion. To evaluate potential biases created by study design,
stratiﬁed analysis (hospital- verses population-based/cohort)
was conducted. For studies where data were available, we
examined whether potential confounders might at least in
part inﬂuence the observed associations between overall alco-
hol intake and lung cancer risk. We examined confounding
by occupational exposure (data available for 5 studies) by
adjusting for study subjects’ job history (whether they held
jobs known or suspected to be associated with excess risk of
lung cancer such as mining, chemical industry, metal reﬁn-
ing, and others).16,17 We also adjusted for previous medical
history of tuberculosis, chronic pulmonary disorder, emphy-
sema or pneumonia (ﬁve studies) and exposure to environ-
mental tobacco smoke (10 studies) in regression models.
Statistical analyses were performed with SAS (SAS Institute,
Inc., Cary, NC) and R (Foundation for Statistical Computing,
Vienna, Austria).
Results
A total of 2548 never-smoking lung cancer patients and 9362
never-smoking controls from the 22 studies were included in
this investigation (Table 1). Mean age of cases and controls
were similar (60.8 for cases, 60.5 for controls). There were
more females among cases (78%) than controls (57%), result-
ing from the original frequency matching by sex being per-
formed in both ever and never smokers combined, with the
tendency for females to be over-represented among cases in
never smoking samples. Cases were slightly more educated
than controls. The majority of the subjects were of European
descent. Cases were less likely to be of European descent
than controls due to the large number of controls from the
European-based EPIC study where frequency matching
included ﬁve controls per case.
Overall alcohol consumption
The associations between average lifetime alcohol consump-
tion and lung cancer risk by consumption categories are pre-
sented in Table 2. Low to moderate alcohol consumption
was shown to be inversely associated with lung cancer risk
when compared to non-drinkers with ORs of 0.80
(95%CI5 0.70–0.90), 0.82 (95%CI5 0.69–0.99) and 0.79
(95%CI5 0.65–0.96) for the consumption of >0–4.9 g per
day, 5–9.9 g per day, and 10–19.9 g per day, respectively.
Results from analyses stratiﬁed by histologic subtype showed
inverse associations of low, moderate and heavier drinking
with lung adenocarcinoma and squamous cell carcinoma.
The inverse association with squamous cell carcinoma
appeared to be more prominent. However, sample size for
squamous cell carcinoma was limited, given the particularly
strong association of this sub-type with tobacco. In contrast
to these histologic sub-types, risk for small cell carcinoma of
the lung was elevated ranging from 1.2 to 1.7 for all catego-
ries of alcohol consumption above 0–4.9 g per day, although
the conﬁdence limits were wide given the small sample size
(Table 2).
Figure 1 shows the dose-response relationship of average
lifetime alcohol consumption in grams per day against the
odds of being a case for all lung cancer, adenocarcinoma,
squamous cell carcinoma and small cell lung cancer. A nota-
ble drop in the odds of being a case was seen for drinkers
with low to moderate consumptions compared to non-
drinkers for lung cancer overall, adenocarcinoma and squa-
mous cell carcinoma. With increasing alcohol consumption,
the conﬁdence limits widened considerably which did not
permit ﬁrm conclusions of the precise dose-response relation-
ship for higher levels of alcohol intake.
Type of alcohol consumed
The associations between lung cancer risk and lifetime aver-
age consumption by different alcoholic beverage types (wine,
Table 1. Demographic characteristics of study subjects
Characteristics Case no. (%) Control no. (%)
Overall 2548 9362
Sex
Female 1978 (77.6) 5351 (57.2)
Male 570 (22.4) 4011 (42.8)
Age (years)
Mean 60.8 60.5
Standard deviation 11.8 11.6
Age groups
<50 453 (17.8) 1710 (18.3)
50<60 657 (25.8) 2274 (24.3)
60<70 810 (31.8) 3155 (33.7)
701 628 (24.6) 2223 (23.7)
Race/ethnicity
White, European 1511 (59.3) 6600 (70.5)
Black, African-American 67 (2.6) 463 (4.9)
Asian 906 (35.6) 2077 (22.2)
Latino 41 (1.6) 124 (1.3)
Other unknown 23 (0.9) 98 (1.0)
Education
Basic/elementary 567 (22.3) 2152 (23.0)
Up to high school graduate 572 (22.4) 2791 (29.8)
Some postsecondary
and higher
903 (35.4) 2011 (21.5)
Missing or unspecified 506 (19.9) 2408 (25.7)
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beer and liquor) are reported in Table 3. Risk estimates for
wine and liquor consumption were similar to those for over-
all consumption, whereas beer drinking showed statistically
non-signiﬁcant elevations in risk for alcohol consumption of
10 g a day and higher. Low and moderate amounts of wine
drinking were associated with reduced lung cancer risk (>0–
4.9 g per day: OR5 0.80, 95% CI5 0.69–0.94; 20–29 g per
day: OR5 0.62, 95% CI5 0.43–0.89), while low amount of
liquor drinking was associated with reduced lung cancer risk
(0–4.9 g per day: OR5 0.77, 95% CI5 0.66–0.91). Trends for
beer consumption differed from those for wine and liquor
with point estimates being above 1 for moderate to high
drinking categories (>10 g per day) suggesting positive asso-
ciations (Table 3).
Evaluation of effect modifiers and potential confounders
Associations between alcohol consumption and lung cancer
risk were similar when stratiﬁed by gender. A signiﬁcant inverse
association with lower amounts of drinking was observed in
females with OR of 0.80 (95% CI5 0.69–0.93), while the esti-
mate in males was comparable with OR of 0.89 (0.68–1.17)
(Supporting Information Table 3). The lack of signiﬁcance in
males may simply be due to the smaller sample size.
When we analyzed population-based and cohort studies
separately from hospital-based studies, we found that signiﬁ-
cantly reduced odds ratios were restricted to the population-
based/cohort studies. Risk estimates for the hospital-based
study group did not provide strong evidence for an associa-
tion with lung cancer risk (Supporting Information Table 4).
Table 2. Risk estimates and 95% CI by histological type and average amount of alcohol consumed per day.
Histological type
Average alcohol
consumption (g/day) Case no. (%) Control no. (%) OR 95% CI
All lung cancer1
Non-drinker 1338 (52.5) 3488 (37.3) 1.00 Reference
>0-4.9 632 (24.8) 2607 (27.8) 0.80 0.70, 0.90
5-9.9 217 (8.5) 1111 (11.9) 0.82 0.69, 0.99
10-19.9 189 (7.4) 1100 (11.7) 0.79 0.65, 0.96
20-29.9 78 (3.1) 445 (4.8) 0.82 0.62, 1.09
30-44.9 36 (1.4) 306 (3.3) 0.68 0.47, 0.99
451 58 (2.3) 305 (3.3) 0.91 0.65, 1.29
Adenocarcinoma1
Non-drinker 702 (50.9) 3488 (37.3) 1.00 Reference
>0-4.9 376 (27.3) 2607 (27.8) 0.82 0.70, 0.96
5-9.9 132 (9.6) 1111 (11.9) 0.91 0.72, 1.14
10-19.9 98 (7.1) 1100 (11.7) 0.74 0.58, 0.96
20-29.9 34 (2.5) 445 (4.8) 0.67 0.45, 0.99
30-44.9 13 (0.9) 306 (3.3) 0.46 0.26, 0.83
451 24 (1.7) 305 (3.3) 0.72 0.44, 1.18
Squamous cell carcinoma2
Non-drinker 91 (52.9) 3271 (37.7) 1.00 Reference
>0-4.9 36 (20.9) 2407 (27.7) 0.51 0.33, 0.78
5-9.9 15 (8.7) 1066 (12.3) 0.49 0.28, 0.89
10-19.9 15 (8.7) 1040 (12.0) 0.51 0.28, 0.92
201 15 (8.7) 903 (10.4) 0.51 0.27, 0.95
Small cell lung cancer3
Non-drinker 27 (43.5) 2266 (32.6) 1.00 Reference
>0-4.9 8 (12.9) 2033 (29.3) 0.47 0.21, 1.10
5-9.9 9 (14.5) 849 (12.2) 1.45 0.64, 3.29
10-19.9 7 (11.3) 862 (12.4) 1.23 0.49, 3.07
201 11 (17.7) 933 (13.4) 1.68 0.70, 4.06
1Adjusted for age group, sex, ethnicity, education and center/sub-centre. Includes all studies.
2Adjusted for age group, sex, ethnicity, education, and centre (included: Aichi, CAPUA, CE, China, EAGLE, EPIC, ESTHER, FHS, HSPH, Hawaii, ICARE,
Israel, Montreal, NCI-Maryland, Moffitt, Seoul, Toronto, UCLA).
3Adjusted for age group, sex, ethnicity, education, and centre (included: Aichi, CAPUA, CE, China, EAGLE, EPIC, ESTHER, FHS, ICARE, Spain, Toronto, UCLA).
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Data for occupational exposure were available for 5 stud-
ies (CE, CAPUA, EAGLE, Montreal, Toronto: 494 cases,
2496 controls). No appreciable changes in odds ratios were
found when variables representing lung cancer related occu-
pational exposures were added to logistic regression models.
Adjustment for medical history of tuberculosis, chronic pul-
monary disorder, emphysema or pneumonia for 5 studies for
which data were available (CE, FHS, NELCS, Toronto,
UCLA, WELD: 516 cases, 2439 controls) also had negligible
effects on odds ratios. We found no appreciable differences
in odds ratios when controlling for exposure to environmen-
tal tobacco smoke (10 studies CE, EPIC, UCLA, FHS, Har-
vard, Hawaii, Mofﬁtt, NELCS, Toronto, WELD: 851 cases,
3261 controls) (data not shown).
Discussion
In this study, the largest conducted on the association of
alcohol consumption with lung cancer risk among never
Figure 1. Non-linear dose response relationship between alcohol consumption and lung cancer risk among never smokers based on
restricted cubic splines. X-axis is grams of alcohol consumed per day and Y-axis is the fitted odds of being a case versus being a control,
adjusted for sex, age, ethnicity, education and center. [Color figure can be viewed at wileyonlinelibrary.com]
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smokers, we found an inverse association between overall
alcohol consumption and lung cancer risk with reduced risk
estimates most consistently observed for low and moderate
drinking. We also found alcohol consumption was associated
with lower risk of both adenocarcinoma and squamous cell
carcinoma. Analysis by alcoholic beverage type revealed that
wine drinkers and liquor drinkers were at lower risk for lung
cancer, with beer drinkers having modest non-signiﬁcant
increases in risk relative to non-drinkers for most drinking
categories.
Consistent with our results, other large studies (including
both ever and never smokers) found reduced lung cancer risk
for lower levels of alcohol consumption. The NIH-AARP
Diet and Health Study, a prospective cohort study, reported
lower risk among drinkers who consumed <12 g (1 drink) of
alcohol per day18 while Freudenheim et al. using a pooled
analysis of cohort studies, found lower risk for women who
drank <15 g of alcohol per day.8 A comprehensive meta-
analysis by Bagnardi et al. (26,509 cases), also reported
reduced risk for low levels of drinking (<12.5 g per day).19
Speciﬁcally for never smokers, previous studies have not pro-
vided consistent evidence regarding alcohol consumption to
lung cancer risk. A meta-analysis by Bagnardi et al. found no
differences in risk between ever and never drinkers10. Among
larger prospective cohort studies, one study found lung can-
cer risk increased with increased drinking in never smoking
males but not females,8 while two other studies reported null
results.15,18
We found differential associations by beverage type with
inverse associations found for both wine and liquor con-
sumption, but not beer consumption. Among larger studies
that investigated association by beverage type (including both
ever and never smokers), inverse associations for low levels
of wine drinking (<12 g or 1 drink per day), but positive
associations with liquor drinking.7 However, similar to our
results, the NIH-AARP Diet and Health Study (the largest
cohort study investigating this association with 10,227 lung
cancer cases) also found low to moderate consumption of
wine or liquor was associated with reduced lung cancer
risk.18 Consistent with our data, larger studies have reported
positive associations between beer consumption and lung
cancer risk.7,18
Our results are compatible with the hypothesis that ﬂavo-
noids found in wine may reduce the risk of some cancers.
Support for a beneﬁcial role of ﬂavonoids is provided by sev-
eral studies where higher dietary intake of ﬂavonoids (includ-
ing ﬂavonols, ﬂavanones and quercetin) was inversely
associated with lung cancer risk.20–22 The inverse association
Table 3. Risk estimates and 95% CI by beverage type and average amount of alcohol consumed per day.
Beverage type
Average alcohol
consumption (g/day) Case no. (%) Control no. (%) OR 95% CI
Wine
Non-drinker 1138 (58.6) 3377 (43.7) 1.00 Reference
>0–4.9 480 (24.7) 2387 (30.9) 0.80 (0.69,0.94)
5–9.9 133 (6.9) 767 (9.9) 0.87 (0.69,1.10)
10–19.9 102 (5.3) 552 (7.2) 0.84 (0.65,1.09)
20–29.9 41 (2.1) 372 (4.8) 0.62 (0.43,0.89)
301 47 (2.4) 266 (3.5) 0.94 (0.64,1.38)
Beer
Non-drinker 1427 (73.5) 4647 (60.2) 1.00 Reference
>0–4.9 378 (19.5) 2221 (28.8) 0.95 0.81, 1.11
5–9.9 55 (2.8) 453 (5.9) 0.91 0.66, 1.26
10–19.9 41 (2.1) 229 (3.0) 1.20 0.82, 1.75
20–29.9 19 (1.0) 79 (1.0) 1.54 0.90, 2.65
301 21 (1.1) 92 (1.2) 1.35 0.78, 2.33
Liquor
Non-drinker 1459 (75.2) 4806 (62.3) 1.00 Reference
>0–4.9 383 (19.7) 2382 (30.9) 0.77 (0.66, 0.91)
5–9.9 42 (2.2) 233 (3.0) 0.82 (0.56, 1.19)
10–19.9 30 (1.6) 137 (1.8) 0.87 (0.56, 1.36)
20–29.9 18 (0.9) 73 (1.0) 1.03 (0.59, 1.81)
301 9 (0.5) 90 (1.2) 0.41 (0.19, 0.86)
Adjusted for alcohol type (i.e. mutual adjustment for wine, beer, and liquor) age group, sex, ethnicity, education, and centre/sub-center. Includes:
CAPUA, CE, China, EAGLE, EPIC, ESTHER, FHS, HSPH, HAWAII, ICARE, Israel, Montreal, NCI-Maryland, NELC, Moffitt, Spain, Toronto, UCLA, WELD.
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between liquor consumption and lung cancer risk is more
difﬁcult to explain. It is possible that constituents of different
beverage types have no direct effect on risk, but instead bev-
erage type is correlated with lifestyle factors that are associat-
ed with lung cancer risk. For example, wine drinkers have
been reported to have healthier diets than beer drinkers in
several studies.23–26 A healthier diet for both wine and liquor
drinkers relative to beer drinkers has also been reported, but
not consistently.23,24,26
We observed differential association of lung cancer risk
across different histologic sub-types, with inverse associations
found between alcohol consumption and adenocarcinoma
and squamous cell carcinoma but not for small cell lung car-
cinoma. Our ﬁnding of reduced risk for squamous cell carci-
noma among alcohol consumers is in part supported by the
NIH-AARP Diet and Health Study where reduced risk of
squamous cell carcinoma was found among low and moder-
ate drinkers (<3 drinks per day) of alcohol.18 However, in
general, results pertaining to the association of alcohol con-
sumption with histologic sub-type of lung cancer in com-
bined samples of ever and never smokers have been
mixed.8,18,27 In addition to random variation it is possible
that heterogeneity in results could be at least partially attrib-
uted to confounding by smoking, which can vary across pop-
ulations and is differentially associated with different
histologic subtypes. Even though our study is restricted to
never smokers, we cannot preclude the possibility of residual
confounding by tobacco smoking. However validation studies
have shown that misclassiﬁcation of never smokers with ever
smokers is unlikely to have an important effect on results28;
therefore the potential residual confounding by tobacco
smoking is not expected to be a driving factor of associations
observed in our study.
In general, neither our categorical data analysis nor our
analysis of non-linearity using restricted cubic splines indicat-
ed that heavy consumers of alcohol have higher lung cancer
risk when comparing to non-drinkers, although we did
observe a suggestive positive association with increased beer
consumption. In most analyses, we found risk estimates were
generally below the null for subjects who were categorized as
heavier drinkers (30 or more grams per day) of total alcohol,
wine or liquor. In contrast, results from several large cohort
studies and a recent comprehensive meta-analysis indicated
increased risk for heavier drinkers.8,11,18,19 As these studies
included smokers, residual confounding by smoking in heavi-
er drinkers may explain the observed increased risk of lung
cancer. Two recent cohort studies and a meta-analysis did
not ﬁnd heavier drinkers to be at higher risk for lung cancer
among never smokers.10,11,18
The observed inverse associations we found between alco-
hol consumption and lung cancer risk may be explained by
confounding related to differences between non-drinkers and
drinkers. It has been postulated that non-drinkers may repre-
sent a unique subgroup of the population with either lower
socio-economic status or medical conditions that could
confound associations with lung cancer. Although we have
controlled for confounding by socio-economic status by
adjusting for education in logistic regression models, it is
possible that this measure did not fully capture socio-
economic status. To account for potential comorbidity, we
also adjusted for medical history of tuberculosis, chronic pul-
monary disorder, emphysema or pneumonia in a subset of
our study where these data were available. We found no
appreciable effects on odds ratios. Even though we did not
observe any evidence of confounding based on socio-
economic status or medical conditions, our results are com-
patible with the hypothesis that non-drinkers are a unique
group of individuals which can drive the dose response rela-
tionship to show inverse associations with point estimates
below the null throughout different categories of drinking.
To investigate whether study design could have introduced
bias into our results, we compared results by study design
(cohort, population-based and hospital-based case-control
studies). Interestingly, inverse associations between alcohol
consumption and lung cancer risk were found only for the
population-based studies. The most noticeable difference
between the three sub-groups was that controls in hospital
based studies were more likely to identify themselves as never
drinkers than those in the population-based or cohort studies
(Supporting Information Table 4). A possible explanation for
this is that controls recruited in the hospital-based studies may
be more likely to abstain from alcohol due to other health con-
ditions, and this resulted in associations remaining near the
null in this sub-group. Given that most of the studies are based
on case-control design, we cannot preclude the possibility of
recall bias, which could further explain the lack of dose
response, although it would not explain how recall bias would
result in the observed association particularly in population-
based case-control studies. Ideally, one would hope to address
the recall issue in the prospective study; however we had limit-
ed number of non-smoking lung cancer cases from cohort
study to be informative (Supporting Information Table 4). We
also stratiﬁed our subjects by sex since men and women metab-
olize alcohol differently. However, we did not ﬁnd important
differences in risk estimates between the sexes.
Although our results are consistent with wine and liquor
consumption associated with a reduced risk of lung cancer,
we cannot rule out residual confounding from known or
unknown factors inﬂuencing observed associations with lung
cancer risk. Recent results from Mendelian randomization
studies conﬂict with the commonly cited view that light to
moderate alcohol consumption is causally linked to lower
risk for ischaemic heart disease, with results from genetic
analyses clearly indicating that genetic variation that predis-
poses to less drinking is associated with lower risk in both
light/moderate and heavier drinkers.29 This emphasizes the
potential importance of confounding in studies that investi-
gate associations between alcohol consumption and chronic
diseases.
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In summary, based on the largest study of alcohol consump-
tion and lung cancer for never smokers to date, we investigated
detailed dose-response relationships and potential effect modi-
ﬁers by beverage type and histological subtype. We found an
inverse association between wine and liquor consumption and
lung cancer risk in never smokers. We cannot, however, rule
out residual confounding from known or unknown risk factors
inﬂuencing the observed associations with lung cancer risk, par-
ticularly those related to non-drinkers. Further research is need-
ed to clarify associations between alcohol consumption and
lung cancer risk with a focus on reducing or elucidating the role
of confounding a priority for future studies.
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